LYRA
Price
$9.00
Change
-$0.31 (-3.33%)
Updated
Jul 3 closing price
Capitalization
15.74M
37 days until earnings call
VERA
Price
$24.00
Change
+$0.35 (+1.48%)
Updated
Jul 3 closing price
Capitalization
1.53B
32 days until earnings call
Interact to see
Advertisement

LYRA vs VERA

Header iconLYRA vs VERA Comparison
Open Charts LYRA vs VERABanner chart's image
Lyra Therapeutics
Price$9.00
Change-$0.31 (-3.33%)
Volume$43.49K
Capitalization15.74M
Vera Therapeutics
Price$24.00
Change+$0.35 (+1.48%)
Volume$629.76K
Capitalization1.53B
LYRA vs VERA Comparison Chart in %
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. VERA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Hold and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (LYRA: $9.00 vs. VERA: $24.00)
Brand notoriety: LYRA and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 5% vs. VERA: 31%
Market capitalization -- LYRA: $15.74M vs. VERA: $1.53B
LYRA [@Biotechnology] is valued at $15.74M. VERA’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • LYRA’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, both LYRA and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 2 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • LYRA’s TA Score: 2 bullish, 6 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than LYRA.

Price Growth

LYRA (@Biotechnology) experienced а -32.74% price change this week, while VERA (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

LYRA is expected to report earnings on Aug 12, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.53B) has a higher market cap than LYRA($15.7M). LYRA YTD gains are higher at: -12.791 vs. VERA (-43.249). LYRA has higher annual earnings (EBITDA): -44.7M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. LYRA (31.7M). LYRA has less debt than VERA: LYRA (33.4M) vs VERA (54.5M). LYRA has higher revenues than VERA: LYRA (1.19M) vs VERA (0).
LYRAVERALYRA / VERA
Capitalization15.7M1.53B1%
EBITDA-44.7M-167.77M27%
Gain YTD-12.791-43.24930%
P/E RatioN/AN/A-
Revenue1.19M0-
Total Cash31.7M590M5%
Total Debt33.4M54.5M61%
TECHNICAL ANALYSIS
Technical Analysis
LYRAVERA
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLYX72.170.77
+1.08%
JHancock U.S. Global Leaders Growth R2
PLAAX16.110.17
+1.07%
PACE Large Co Growth Equity A
SGAPX24.750.24
+0.98%
Virtus SGA Global Growth I
DHFYX13.960.06
+0.43%
Diamond Hill Large Cap Concentrated Y
PRIKX15.41N/A
N/A
T. Rowe Price Real Assets I

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-3.33%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
+0.62%
VERA - LYRA
54%
Loosely correlated
+1.48%
KYMR - LYRA
50%
Loosely correlated
+0.58%
BPMC - LYRA
41%
Loosely correlated
+0.12%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+1.48%
KYMR - VERA
54%
Loosely correlated
+0.58%
LYRA - VERA
54%
Loosely correlated
-3.33%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
47%
Loosely correlated
+0.12%
BNTX - VERA
40%
Loosely correlated
+1.61%
More